Your life is too short for trial delays

Budget overruns and clinical trial delays have become the norm. But do they have to be? 

On-time enrollment in pivotal Phase 2 & 3 clinical trials

> 90% repeat and referral rate for clients

Extensive and diverse team of experts across 58 countries

How does it happen?

We meet deadlines and enrollment milestones, time and time and time again. In fact, you could say our obsession with timelines is something of an unfair advantage. We’ve built a name by coming to the rescue when trials fall behind and sponsors have to start from scratch. “We Can Do Hard Things” is one of our rallying cries, and it’s true.

On-time delivery goes hand in hand with world class service. In an industry where being behind schedule is considered par for the course, we dare to buck the trend. It’s time to choose the CRO you can trust.

Ready to push your trial ahead?

Here are three simple first steps on the way to a successful trial:

1. Contact us to schedule a call

2. Submit an RFP

3. Launch your trial on time

Don’t put up with poor performance. For 30 years PSI has built such trusted relationships with biopharma sponsors, that 90% of our customers are repeat and referral.

 

Save Time

We know that the industry is riddled with delays. In fact, 90% of trials aren’t on schedule. But at PSI, we deliver on time, over and over again. In fact, we’re even known to enroll ahead of time.

Save Money 

Your product is important, and your team has the potential to change lives for patients all around the world. Save money by choosing the right CRO from the beginning. Our budgets are tried and true, and we’ll be on target the entire time.

Save Reputation

We deliver quality, and we deliver on time. Our teams work tirelessly to ensure your study and the reputation of your product will speak volumes.

PSI was flexible to meet the various challenges in clinical trial conduct. The rapid enrollment of patients and the quick study close out allowed on-time study completion

Newsroom

blank pill bottles on a purple background
Case Study

Winning the Biosimilar Race: Trastuzumab Biosimilar Phase III Breast Cancer Study

Trusted to Deliver

When you partner with PSI, you work with a team recognized by independent industry organizations and sponsor surveys for what matters most in clinical research: expertise, consistent operational excellence, and reliable delivery.